Where EcoR1 stands to profit from healthy deal making
From Institutional Investor: These are busy times for the folks at Oleg Nodelman s EcoR1 Capital, an investment firm focused on therapeutic companies in the biotechnology sector. Silverback Therapeutics, a clin….
Article Link